Literature DB >> 22860226

Oxidative stress effect of dopamine on α-synuclein: electroanalysis of solvent interactions.

Tiffiny Chan1, Ari M Chow, Xin R Cheng, Derek W F Tang, Ian R Brown, Kagan Kerman.   

Abstract

The interaction of dopamine (DA) and α-synuclein (α-S) can lead to protein misfolding and neuronal death triggered by oxidative stress relevant to the progression of Parkinson's disease (PD). In this study, interfacial properties associated with DA-induced α-S aggregation under various solution conditions (i.e., pH, ionic strength) were investigated in vitro. The electrochemical oxidation of tyrosine (Tyr) residues in α-S was detected in the presence of DA. DA concentration dependence was analyzed and found to significantly affect α-S aggregation pathways. At low pH, DA was shown to be stable and produced no observable difference in interfacial properties. Between pH 7 and 11, DA promoted α-S aggregation. Significant differences in oxidation current signals in response to high pH and ionic strength suggested the importance of initial interactions in the stabilization of toxic oligomeric structures and subsequent off-pathways of α-S. Our results demonstrate the importance of solution interactions with α-S and the unique information that electrochemical techniques can provide for the investigation of α-S aggregation at early stages, an important step toward the development of future PD therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22860226      PMCID: PMC3399574          DOI: 10.1021/cn300034t

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  33 in total

1.  A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation.

Authors:  Mun'delanji Vestergaard; Kagan Kerman; Masato Saito; Naoki Nagatani; Yuzuru Takamura; Eiichi Tamiya
Journal:  J Am Chem Soc       Date:  2005-08-31       Impact factor: 15.419

2.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  alpha-Synuclein affects the MAPK pathway and accelerates cell death.

Authors:  A Iwata; M Maruyama; I Kanazawa; N Nukina
Journal:  J Biol Chem       Date:  2001-09-17       Impact factor: 5.157

4.  Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations.

Authors:  P J McLean; H Kawamata; S Ribich; B T Hyman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

5.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

6.  Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.

Authors:  Joseph R Mazzulli; Amanda J Mishizen; Benoit I Giasson; David R Lynch; Steven A Thomas; Akira Nakashima; Toshiharu Nagatsu; Akira Ota; Harry Ischiropoulos
Journal:  J Neurosci       Date:  2006-09-27       Impact factor: 6.167

Review 7.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

8.  Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode.

Authors:  Miyuki Chikae; Tomohiro Fukuda; Kagan Kerman; Koutarou Idegami; Yoshiko Miura; Eiichi Tamiya
Journal:  Bioelectrochemistry       Date:  2008-06-12       Impact factor: 5.373

9.  Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction.

Authors:  Andre Hermans; Richard B Keithley; Justin M Kita; Leslie A Sombers; R Mark Wightman
Journal:  Anal Chem       Date:  2008-04-24       Impact factor: 6.986

10.  Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.

Authors:  Chi L L Pham; Su Ling Leong; Feda E Ali; Vijaya B Kenche; Andrew F Hill; Sally L Gras; Kevin J Barnham; Roberto Cappai
Journal:  J Mol Biol       Date:  2009-02-11       Impact factor: 5.469

View more
  6 in total

1.  Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF.

Authors:  Ofelia M Littrell; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

Review 2.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

3.  Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.

Authors:  Xiaohong Wang; Lei Pang; Yanqing Zhang; Jiang Xu; Dongyi Ding; Tianli Yang; Qian Zhao; Fan Wu; Fei Li; Haiwei Meng; Duonan Yu
Journal:  Neurochem Res       Date:  2018-03-28       Impact factor: 3.996

4.  Double molecular recognition strategy based on boronic acid-diol and NHS ester-amine for selective electrochemical detection of cerebral dopamine.

Authors:  Hui Gu; Yanqiu Guo; Xia Xiao; Chenchen Li; Guoyue Shi; Jian He
Journal:  Anal Bioanal Chem       Date:  2020-04-29       Impact factor: 4.142

Review 5.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

6.  Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States.

Authors:  Eva Illes-Toth; Caroline F Dalton; David P Smith
Journal:  J Am Soc Mass Spectrom       Date:  2013-07-02       Impact factor: 3.109

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.